What is Transpact Enterprises share price return in the past 10 years?

Data is not available for this company

What is the P/E ratio of Transpact Enterprises?

The latest standalone P/E ratio of Transpact Enterprises as of 11-Apr-2025 is 0.00.

What is the P/B ratio of Transpact Enterprises?

The latest standalone P/B ratio of Transpact Enterprises as of 11-Apr-2025 is 18.53.

Transpact Enterprises Ltd - Stock Valuation and Financial Performance

Name: Transpact Enterprises
Brand: Transpact Enterprises

BSE: 542765 | NSE: | Medical Equipment/Supplies/Accessories | Small Cap

Place order

Transpact Enterprise Share Price

₹212 9.00 4.43%
as on 11-Apr'25 16:59

DeciZen - make an informed investing decision on Transpact Enterprise

Based on:

Data

M-Cap below 100cr DeciZen not available

Transpact Enterprises stock performance -

PE Chart Key Ratios

P/E Ratio (SA):

0.00

Market Cap:

8.2 Cr.

52-wk low:

130.6

52-wk high:

380

Related Stocks

Is Transpact Enterprises Ltd an attractive stock to invest in?

1. Is Transpact Enterprises Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Transpact Enterprises Ltd is a below average quality company.

2. Is Transpact Enterprises Ltd undervalued or overvalued?

The key valuation ratios of Transpact Enterprises Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Transpact Enterprises Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Transpact Enterprises Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Transpact Enterprise:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Standalone Basis ^P Consolidated Basis

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

Value Creation Index Colour Code Guide ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
ROCE % ⓘ	-19.5%	-27.6%	-66.2%	-53.6%	-5.2%	-21.9%	-7.9%	-14.5%	-
Value Creation Index ⓘ	-2.4	-3.0	-5.7	-4.8	-1.4	-2.6	-1.6	-2.0	-
Growth Parameters ⓘ Growth Parameters Colour Code Guide ⓘ
Sales ⓘ	0	0	0.1	0	0	0.2	0.4	0	0
Sales YoY Gr.	-	NA	NA	-100%	NA	400%	153.3%	-100%	-
Adj EPS ⓘ	-1.6	-3.2	-10.6	-11.2	-1.7	-5.7	-1.7	-2.4	-2.4
YoY Gr.	-	NA	NA	NA	NA	NA	NA	NA	-
BVPS (₹) ⓘ	5.8	2.6	0.1	22.9	21.2	15.5	13.8	11.4	11.4
Adj Net Profit ⓘ	-0.1	-0.1	-0.3	-0.4	-0.1	-0.2	-0.1	-0.1	0
Cash Flow from Ops. ⓘ	-0.1	-0.1	0.1	-1.1	0	-0.9	0	0.6	-
Debt/CF from Ops. ⓘ	-1.4	-0.9	2.8	-0.2	26.2	-0.3	32.4	0.1	-

CAGR ⓘ

CAGR Colour Code Guide ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	NA	-100%	-100%	-100%
Adj EPS ⓘ	NA	NA	NA	NA
BVPSⓘ	NA	185.8%	-18.6%	-17%
Share Price	-	9.5%	12.7%	-47%

Key Financial Parameters ⓘ

Performance Ratio Colour Code Guide ⓘ

	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	TTM
Return on Equity % ⓘ	-27.6	-37.6	-103.9	-76.3	-7.5	-31.1	-11.6	-18.6	-20.5
Op. Profit Mgn % ⓘ	0	0	-202.9	0	-195.7	-138.5	-7.8	0	NAN
Net Profit Mgn % ⓘ	0	0	-229.5	0	-256.7	-147.3	-17.2	0	-INF
Debt to Equity ⓘ	0.4	0.3	0.7	0.3	0.4	0.5	0.5	0.1	-
Working Cap Days ⓘ	0	0	386	0	14,886	2,307	799	0	0
Cash Conv. Cycle ⓘ	0	0	166	0	2,105	46	-74	0	0

Recent Performance Summary

No data to display

Return on Equity is Poor

Sales growth has been subdued in last 3 years -100.00%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Transpact Enterprises Ltd.

	Standalone	Consolidated
TTM EPS (₹)	-2.4	-
TTM Sales (₹ Cr.)	0	-
BVPS (₹.) ⓘ	11.4	-
Reserves (₹ Cr.) ⓘ	-	-
P/BV ⓘ	18.53	-
PE ⓘ	0.00	-

From the Market
52 Week Low / High (₹)	130.60 / 380.00
All Time Low / High (₹)	86.00 / 483.80
Market Cap (₹ Cr.)	8.2
Equity (₹ Cr.)	0.4
Face Value (₹)	10
Industry PE ⓘ	64.7

Quarterly Results

Standalone Basis

Consolidated Basis

	Mar'24	YoY Gr. Rt. %	Jun'24	YoY Gr. Rt. %	Sep'24	YoY Gr. Rt. %	Dec'24	YoY Gr. Rt. %
Sales (₹ Cr.)ⓘ	16.3	18	13.3	-0.4	16.3	23.4	14.9	9.6
Adj EPS (₹) ⓘ	3.9	-8.7	3	-10.6	4	29.2	3.7	22.8
Op. Profit Mgn % ⓘ	36.21	-448 bps	33.63	-345 bps	35.76	156 bps	34.44	160 bps
Net Profit Mgn % ⓘ	28.71	-837 bps	27.37	-312 bps	29.76	137 bps	29.91	323 bps

Management X-Ray of Transpact Enterprise:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Valuation of Transpact Enterprise

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

No data found!

Key Ratios of Transpact Enterprise

Standalone Basis Consolidated Basis

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Peer Comparison

Company Name	CMP(₹)	Change ₹(%)	Market Cap	Net Sales (₹ Cr.)	Latest EPS (₹)	Net Profit Margin %	Latest P/E	Latest P/BV
Poly Medicure	2,139.9	100.8 (4.9%)	Small Cap	1,307	31.1	18.4	65.6	7.8
Hemant Surgical Inds	104	0 (0%)	Small Cap	106	9.4	8.4	11.1	2
Nureca Ltd.	213.9	5.2 (2.5%)	Small Cap	94.5	-7.2	-6.9	-	1.1
Prevest Denpro	509.9	6.9 (1.4%)	Small Cap	56.4	14.7	28.2	34.3	6
Centenial Surgical	114.1	4.8 (4.4%)	Small Cap	51.2	-0.6	2.2	-	1.3
Raaj Medisafe India	70.4	0 (0%)	Small Cap	43.2	2.5	7.7	27.8	4
GKB Ophthalmics	65.5	3.1 (5%)	Small Cap	31.2	-9.9	-11.2	-	1.6
Amkay Products	46	4.9 (12.1%)	Small Cap	31.1	3	8.5	13.5	1.6
Shree Pacetronix	73	0 (0%)	Small Cap	22	4.8	15.1	15.4	2
KMS Medisurgi	125	0 (0%)	Small Cap	13.9	1.7	3.6	72	5.7

Shows rows:

Prev 1 2 Next

Profit And Loss

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Sales	0	0	0.13	0	0.03	0.15	0.38	0
Operating Expenses ⓘ	0.05	0.09	0.39	0.41	0.07	0.36	0.41	0.06
Manufacturing Costs	0	0	0.01	0	0	0	0.01	0
Material Costs	0	0	0.09	0	0	0.28	0.19	0
Employee Cost	0.01	0.04	0.01	0.02	0.03	0.04	0.11	0.02
Other Costs ⓘ	0.03	0.05	0.27	0.39	0.05	0.05	0.10	0.04
Operating Profit ⓘ	-0.05	-0.09	-0.26	-0.41	-0.05	-0.21	-0.03	-0.06
Operating Profit Margin (%)	-	-	-202.0%	-	-195.0%	-138.0%	-7.8%	-
Other Income ⓘ	0	0	0	0.02	0.03	0.03	0	0
Interest ⓘ	0	0	0	0	0	0	0	0
Depreciation ⓘ	0	0	0.02	0.04	0.04	0.04	0.04	0.04
Exceptional Items ⓘ	0	0	0	0	0	0	0	0
Profit Before Tax ⓘ	-0.05	-0.09	-0.29	-0.42	-0.06	-0.22	-0.07	-0.10
Tax ⓘ	0	0	0.01	0.01	0.01	0	0	0
Profit After Tax	-0.05	-0.09	-0.30	-0.43	-0.06	-0.22	-0.07	-0.09
PAT Margin (%)	-	-	-229.0%	-	-256.0%	-147.0%	-17.2%	-
Adjusted EPS (₹)	-1.6	-3.2	-10.6	-11.2	-1.7	-5.7	-1.7	-2.4
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%

Balance Sheet

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Equity and Liabilities
Shareholders Fund	0.16	0.32	0.25	0.88	0.82	0.60	0.53	0.44
Share Capital ⓘ	0.04	0.29	0.29	0.39	0.39	0.39	0.39	0.39
Reserves ⓘ	0.12	0.03	-0.04	0.50	0.43	0.21	0.15	0.06
Minority Interest	0	0	0	0	0	0	0	0
Debt	0.07	0.11	0.18	0.26	0.29	0.29	0.28	0.05
Long Term Debt	0	0	0	0	0	0	0	0
Short Term Debt	0.07	0.11	0.18	0.26	0.29	0.29	0.28	0.05
Trade Payables	0	0.04	0.05	0.11	0.09	0.10	0.06	0.02
Others Liabilities ⓘ	0	0	0.03	0.05	0.18	0.11	0.17	0.14
Total Liabilities ⓘ	0.24	0.47	0.52	1.31	1.38	1.10	1.04	0.66
Fixed Assets
Gross Block	0.18	0.18	0.37	0.37	0.37	0.37	0.37	0.37
Accumulated Depreciation	0	0	0.02	0.06	0.10	0.13	0.17	0.21
Net Fixed Assetsⓘ	0.18	0.18	0.35	0.31	0.27	0.24	0.20	0.16
CWIP ⓘ	0	0.12	0	0	0	0	0	0
Investmentsⓘ	0	0	0	0	0	0	0	0
Inventories	0	0.09	0.09	0.18	0.18	0.01	0.01	0.01
Trade Receivables	0	0	0.03	0	0	0	0	0
Cash Equivalents ⓘ	0.01	0.06	0.01	0.01	0.05	0.02	0.01	0.41
Others Assetsⓘ	0.05	0.02	0.05	0.80	0.87	0.83	0.82	0.07
Total Assets ⓘ	0.24	0.47	0.52	1.31	1.38	1.10	1.04	0.66

Cash Flow

(All Figures are in Crores.)

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Cash Flow From Operating Activity ⓘ	-0.05	-0.11	0.07	-1.14	0.01	-0.87	0.01	0.62
PBT ⓘ	-0.05	-0.09	-0.29	-0.42	-0.06	-0.22	-0.07	-0.10
Adjustment ⓘ	0	0	0.02	0.04	0.04	0.04	0.04	0.04
Changes in Working Capital ⓘ	-0	-0.02	0.33	-0.76	0.03	-0.69	0.04	0.68
Tax Paid ⓘ	0	0	0	0	0	0	0	0
Cash Flow From Investing Activity ⓘ	-0.05	-0.12	-0.19	0	0	0	0	0
Capex	-0.05	-0.12	-0.19	0	0	0	0	0
Net Investments	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	0	0	0	0
Cash Flow From Financing Activityⓘ	0.10	0.29	0.08	1.14	0.03	-0.29	-0.02	-0.22
Net Proceeds from Shares ⓘ	0.08	0.25	0	1.35	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0
Interest Paid ⓘ	0	0	0	0	0	0	0	0
Dividend Paid ⓘ	0	0	0	0	0	0	0	0
Others ⓘ	0.03	0.04	0.08	-0.21	0.03	-0.29	-0.02	-0.22
Net Cash Flow ⓘ	0	0.05	-0.05	0	0.04	-1.16	-0.01	0.39

Finance Ratio

Standalone Basis Consolidated Basis

PARTICULARS	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24
Ratios
ROE (%)	-27.59	-77.28	-804.02	-97.83	-7.53	-31.12	-11.64	-18.63
ROCE (%)	-19.45	-27.62	-66.2	-53.57	-5.23	-21.88	-7.88	-14.52
Asset Turnover Ratio	0	0	0.26	0	0.02	0.12	0.36	0
PAT to CFO Conversion(x)	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Working Capital Days
Receivable Days	0	0	73	0	5	0	0	0
Inventory Days	0	0	253	0	2,658	237	12	0
Payable Days	0	0	183	0	0	125	158	0

Transpact Enterprises Ltd Stock News

View All News

Transpact Enterprises Ltd FAQs

What is the share price of Transpact Enterprise?

Company share prices are keep on changing according to the market conditions. The closing price of Transpact Enterprise on 11-Apr-2025 16:59 is ₹212.0.

What is the market cap of Transpact Enterprise?

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 11-Apr-2025 16:59 the market cap of Transpact Enterprise stood at ₹8.20.

What is the P/E ratio of Transpact Enterprise?

The latest P/E ratio of Transpact Enterprise as of 11-Apr-2025 16:59 is 0.00.

What is the P/B ratio of Transpact Enterprise?

The latest P/B ratio of Transpact Enterprise as of 11-Apr-2025 16:59 is 18.53.

What is the 52-week high and low of Transpact Enterprise?

The 52-week high of Transpact Enterprise is ₹380.0 and the 52-week low is ₹130.6.

What is the TTM revenue of Transpact Enterprise?

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Transpact Enterprise is ₹0.00 ( Cr.) .

About Transpact Enterprises Ltd

Transpact Enterprises

Transpact Enterprises was incorporated as Transpact Enterprises Private Limited on May 12, 2013 under the Companies Act, 1956 with the Registrar of Companies, Mumbai. The certificate of incorporation was issued on May 12, 2013 by the Registrar of Companies, Mumbai at Maharashtra. Further the status of the Company was changed to public limited Company and the name of the company was changed to Transpact Enterprises Limited by a special resolution passed on April 10, 2019. A fresh certificate of incorporation consequent to the change of name pursuant to the conversion into public limited company was granted to the Company on April 16, 2019, by the Registrar of Companies, Mumbai.

Business area of the company

Transpact Enterprises, Maharashtra based is a biotechnology startup. It provides comprehensive & cost-effective products and solutions to specially-abled people. The company is continuously working towards technological innovations and interventions to improve their products. Transpact Enterprises mainly designs, develops and distributes Vestibulator, a therapeutic device. The device has been invented by the Society for Innovation and Entrepreneurship, lIT Bombay. And, Transpact Enterprises holds a license to carry out the commercial activities of Vestibulator. It is a co-patented technology of the company and IRCC-IIT Bombay. The company outsources the manufacturing of the device along with the design details to a 3rd party. With the help of advanced software, the company also offers customized device solutions for patients.

Milestones:

May 2013: Incorporated as 'Transpact Enterprises Private Limited'
June 2015: Entered license agreement with IIT Bombay to carry out all commercialization related activities of Testibulator
December 2015: Filed a patent for the technology of Vestibulator with Controller General of Patents, Designs and Trademarks, Department of Industrial Policy and Promotion, Ministry of Commerce and Industry with IIT Bombay.
September 2016: Received ISO 9001:2015 certification for quality management system
October 2016: Received 13485:2016 certification for 'Medical devices'.
March 2018: Assessed and registered as compliance as per the requirements of Council Directive- Medical Devices Directive– 2007/47/EC by International Standards Registrations.
March 2019: Conversion of Private Company ' Transpact Enterprises Private Limited' to Public Company 'Transpact Enterprises Limited'.